Go BACK

OUH STUDIES

Studies currently being run within Oxford University Hospitals NHS Foundation Trust.

Showing 701 - 710 of 785 studies

NIHR HIC Patient Blood Management and Perioperative Care

Transcranial ultrasound to disrupt pathological oscillations in the brain of people with Parkinson’s Disease and other neurological disorders

Cancer and neoplasms

A Phase 1/2 open-label multi-centre study to assess the safety, pharmacokinetics, and anti-tumour activity of GTAEXS617 in patients with advanced solid tumours

Cancer and neoplasms

A modular, multi-arm, first in human trial to evaluate the safety and tolerability of MDX-124 alone and in combination with anti-cancer treatments, in participants with locally advanced, unresectable or metastatic solid malignancies (ATTAINMENT)

Cancer and neoplasms

An Open-Label, First in Human, Phase 1/2 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of the CTPS1 Inhibitor STP938 in Adult Subjects with Relapsed/Refractory B-Cell and T-Cell Lymphomas

Cardiovascular

Global Clinical Study of Renal Denervation with the Symplicity Spyral Renal Denervation System in Subjects with Uncontrolled Hypertension (SPYRAL AFFIRM)

Infection

D9185C00001, A Phase III, Multicentre, Randomised, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Tozorakimab (MEDI3506) in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen (TILIA)

Cancer and neoplasms

An Exploratory Phase 1b/2a Multicenter, Open-Label, Novel-Novel Combination Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of CC-92480 (BMS-986348) in Novel Therapeutic Combinations in Participants with Relapsed or Refractory Multiple Myeloma (CA057003)

A Window in the Brain 2: Novel quantitative seizure detection tool for paediatric critical care. A multi-centre feasibility study

Extended Patient Diagnostic Imaging